Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.5 USD | -0.69% | +2.60% | -5.24% |
Apr. 24 | Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset | DJ |
Apr. 24 | Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study | MT |
Financials (USD)
Sales 2024 * | 88.39B | Sales 2025 * | 90.87B | Capitalization | 358B |
---|---|---|---|---|---|
Net income 2024 * | 21.05B | Net income 2025 * | 22.24B | EV / Sales 2024 * | 3.97 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.71 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
16
x | Employees | 131,900 |
Yield 2024 * |
3.25% | Yield 2025 * |
3.39% | Free-Float | 77.1% |
Latest transcript on Johnson & Johnson
1 day | -0.59% | ||
1 week | +2.60% | ||
Current month | -6.11% | ||
1 month | -4.32% | ||
3 months | -6.56% | ||
6 months | -1.79% | ||
Current year | -5.24% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 215 M€ | +11.68% | - | |
12.91% | 18 M€ | +3.28% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 148.5 | -0.69% | 9,754,972 |
24-04-23 | 149.6 | +0.30% | 10,110,442 |
24-04-22 | 149.1 | +0.82% | 10,118,694 |
24-04-19 | 147.9 | +1.49% | 9,750,751 |
24-04-18 | 145.7 | +0.67% | 9,887,704 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.24% | 360B | |
+25.61% | 672B | |
+25.87% | 570B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B | |
-5.21% | 147B |
- Stock Market
- Equities
- JNJ Stock